Nima Madanchi

Dr. Nima Madanchi is double boardcertified in internal medicine and rheumatology. After graduating with honors from Tehran University of Medical Sciences the ranked one medical school in Iran, he completed his research fellowship at McGill University in Montreal, Canada. He moved to the Washington, DC in 2017 to pursue his training in Internal Medicine residency at Georgetown University followed by his rheumatology fellowship at the Virginia Commonwealth University. He then pursued his academic career by completing his postdoctoral fellowship at the Lupus Center of Johns Hopkins University ranked one rheumatology division in the nation under supervision of the internationally renowned lupus expert, Dr. Michelle Petri.

He has authored more than 25 publications in the international conferences and medical journals including Arthritis Rheumatology, International Journal of Rheumatic Diseases, Canadian Journal of Kidney Health and Disease, and international journal of cardiology. Among other awards, he won the Best Presentation Award of the 4th Annual Conference of National Medical Association Region II in 2022, and the Second-Best Presentation Award of the North American Young Rheumatology Investigator Forum in 2023. He is a member of the American College of Rheumatology ACR and was an invited speaker at the ACR international conference in 2023.

Dr. Madanchi's areas of interest are rheumatic and autoimmune diseases including lupus, rheumatoid arthritis, psoriatic arthritis, antiphospholipid syndrome, rheumatic diseases in pregnancy, as well as osteoarthritis, gout, and joint injections.

Some of Dr. Madanchis abstracts and publications are listed below:
Prevalence and Predictors of Sustained RemissionLow Disease Activity After Discontinuation of Induction or Maintenance Treatment with Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Systematic and Scoping Review.
Risk factors of Bone loss in Systemic Lupus Erythematosus.
Association Between Vitamin D, Body Mass Index, and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus
Diagnostic Approach to Identifying Small Fiber Neuropathy in Patients with Sarcoidosis.
Possible Association Between COVID-19 Infection and de Novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
The Relationship between Plasma Homocysteine Level and HLA-B51 in Patients with Behcet's Disease: a Case-control Study.
Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.